SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-023506
Filing Date
2023-02-21
Accepted
2023-02-21 07:01:22
Documents
1
Period of Report
2023-02-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm237110-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm237110-2_4seq1.xml 4 4094
  Complete submission text file 0001104659-23-023506.txt   5479
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Issuer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SELECTA BIOSCIENCES, INC. 480 ARSENAL WAY WATERTOWN MA 02472
Business Address
Dahms Bradford D. (Reporting) CIK: 0001787307 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40869 | Film No.: 23645217